ZQ Capital

Profile

ZQ Capital is a cross-border private equity firm based in Hong Kong, founded in 2016 by Simon Shen, a former Goldman Sachs and Barclays executive. The firm operates with a team of experienced investment professionals located across Hong Kong, Shanghai, Singapore, and Zurich. What differentiates ZQ Capital is its focus on leveraging its extensive networks in Asia to drive value for Western companies looking to expand in the region. With a strong emphasis on operational improvement, the firm plays an active role in expanding its portfolio companies' Asian footprint.

ZQ Capital's investment strategy targets late-stage, small- to mid-cap companies primarily in developed markets such as the U.S. and Europe. These companies, though market leaders with solid fundamentals, often have limited presence in Asia. ZQ Capital's entry check sizes typically range from $50-100 million, allowing them to acquire controlling stakes. They possess a diversified portfolio across sectors like consumer, education, healthcare, environmental services, and finance. Notably, their recently closed $300 million Asian Growth Fund is designed to aid Western companies in scaling in Asia by providing the necessary financial and network support.

Among ZQ Capital's notable investments are UK-based Allergy Therapeutics and other leading Western companies. As ZQ Capital invests in a small number of buyout transactions, it looks to generate long-term value through its 'invest and build' approach, positioning its portfolio to capitalize on the growth opportunities presented by the Asian market.